Altimmune, Inc. in 1 story
The narratives ALT currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
ALT in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Pemvidutide offers direct exposure to the obesity and metabolic-liver-disease markets, including demand for therapies with favorable body-composition outcomes.
Bear side
0 storiesNo bear-side stories for ALT yet.